Two Sigma Investments’s Marker Therapeutics MRKR Stock Holding History

Two Sigma Investments’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$79.3K	Sell	61,001 -37,140	-38%	-$58.9K	﹤0.01%	4413
2025 Q4	$146K	Buy	98,141 +61,601	+169%	+$69.8K	﹤0.01%	3809
2025 Q3	$32.6K	Buy	+36,540	New	+$45.1K	﹤0.01%	3565
2023 Q1	–	Sell	-1,590	Closed	-$4.23K	–	3113
2022 Q4	$4.23K	Sell	1,590 -3,805	-71%	-$13.1K	﹤0.01%	2753
2022 Q3	$20K	Sell	5,395 -12,122	-69%	-$44.5K	﹤0.01%	2381
2022 Q2	$58K	Sell	17,517 -8,055	-31%	-$26.8K	﹤0.01%	2332
2022 Q1	$113K	Sell	25,572 -32,838	-56%	-$188K	﹤0.01%	2419
2021 Q4	$555K	Sell	58,410 -30,291	-34%	-$402K	﹤0.01%	3142
2021 Q3	$1.5M	Sell	88,701 -11,332	-11%	-$232K	﹤0.01%	2242
2021 Q2	$2.79M	Buy	100,033 +89,113	+816%	+$2.35M	0.01%	1601
2021 Q1	$245K	Buy	+10,920	New	+$250K	﹤0.01%	3491

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Two Sigma Investments's MRKR Position: Q1 2026 in Review

Two Sigma Investments reduced its Marker Therapeutics (MRKR) stake by 38% in Q1 2026, selling an estimated $58.9K and leaving 61,001 shares worth $79.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4413.

Two Sigma Investments first reported a position in MRKR in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.79M in Q2 2021. 35 funds tracked by Wall St. Rank hold MRKR as of Q1 2026.

Two Sigma Investments held 61,001 shares of Marker Therapeutics worth $79.3K as of Q1 2026.
Two Sigma Investments sold 37,140 Marker Therapeutics shares in Q1 2026, an estimated $58.9K.
Marker Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4413 holding.
Two Sigma Investments first reported a position in Marker Therapeutics in Q1 2021 and has held it in 11 quarters since.
Two Sigma Investments's Marker Therapeutics position peaked at $2.79M in Q2 2021.
35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.